trial · primary record
Reduced-intensity hematopoietic stem cell
DOCK8 Deficiency
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 76 |
| Primary completion | 2028-10-31 |
| Primary endpoint | Feasibility |
| Registry ID | NCT01176006 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:47.654Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT01176006
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.